1. Home
  2. BX vs SNY Comparison

BX vs SNY Comparison

Compare BX & SNY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Blackstone Inc.

BX

Blackstone Inc.

HOLD

Current Price

$128.29

Market Cap

116.4B

Sector

Finance

ML Signal

HOLD

Logo Sanofi ADS

SNY

Sanofi ADS

HOLD

Current Price

$47.61

Market Cap

107.3B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BX
SNY
Founded
1985
1994
Country
United States
France
Employees
N/A
74846
Industry
Investment Managers
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
116.4B
107.3B
IPO Year
2007
N/A

Fundamental Metrics

Financial Performance
Metric
BX
SNY
Price
$128.29
$47.61
Analyst Decision
Buy
Buy
Analyst Count
16
5
Target Price
$161.25
$58.00
AVG Volume (30 Days)
6.2M
2.9M
Earning Date
04-23-2026
04-23-2026
Dividend Yield
3.64%
3.33%
EPS Growth
6.91
N/A
EPS
3.87
N/A
Revenue
$14,450,265,000.00
N/A
Revenue This Year
$14.23
$3.86
Revenue Next Year
$21.79
$5.64
P/E Ratio
$33.72
$6.14
Revenue Growth
9.22
N/A
52 Week Low
$101.73
$43.32
52 Week High
$190.09
$55.73

Technical Indicators

Market Signals
Indicator
BX
SNY
Relative Strength Index (RSI) 65.74 56.99
Support Level $125.27 $46.88
Resistance Level $136.49 $48.49
Average True Range (ATR) 4.33 0.71
MACD 2.49 0.10
Stochastic Oscillator 83.94 65.94

Price Performance

Historical Comparison
BX
SNY

About BX Blackstone Inc.

Blackstone is the world's largest alternative-asset manager with $1.242 trillion in total asset under management, including $906.2 billion in fee-earning assets under management, at the end of September 2025. The company operates with scale in each of its major product lines: private equity (26% of fee-earning AUM and 33% of base management fees), real estate/real assets (31% and 35%), private credit (34% and 25%), and other alternatives (9% and 7%). While the firm primarily serves institutional investors (84% of AUM), it also caters to clients in the high-net-worth channel (16%). Blackstone operates through 25 offices in the Americas (8), Europe and the Middle East (9), and the Asia-Pacific region (8).

About SNY Sanofi ADS

Sanofi develops and markets drugs with a concentration in immunology, vaccines, and rare diseases. Although the company offers a diverse array of drugs, its highest revenue generator, Dupixent, accounts for over 30% of total sales. Profits for this immunology blockbuster drug are shared with Regeneron. About 45% of total revenue comes from the United States, 20% from Europe, and 6% from China.

Share on Social Networks: